<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36611921</PMID><DateCompleted><Year>2023</Year><Month>01</Month><Day>10</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>10</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2073-4409</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Dec</Month><Day>28</Day></PubDate></JournalIssue><Title>Cells</Title><ISOAbbreviation>Cells</ISOAbbreviation></Journal><ArticleTitle>Rhinovirus Suppresses TGF-&#x3b2;-GARP Presentation by Peripheral NK Cells.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">129</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/cells12010129</ELocationID><Abstract><AbstractText>Asthma is a chronic airway disease whose exacerbations are often triggered by rhinovirus infection. TGF-&#x3b2;1 induces rhinovirus replication in infected cells. Moreover, TGF-&#x3b2;1 is a pleiotropic mediator that is produced by many immune cells in the latent, inactive form bound to the latency-associated peptide (LAP) and to the transmembrane protein glycoprotein A repetitions predominant (GARP). In this study we wanted to investigate the effect of rhinovirus infection on the TGF-&#x3b2; secretion and the downstream signaling via TGF-&#x3b2;RI/RII in peripheral blood mononuclear cells from control and asthmatic patients after rhinovirus infection ex vivo. Here, we found a significant upregulation of TGF-&#x3b2;RII in untouched PBMCs of asthmatics as well as a suppression of TGF-&#x3b2; release in the rhinovirus-infected PBMC condition. Moreover, consistent with an effect of TGF-&#x3b2; on Tregs, PBMCs infected with RV induced Tregs, and TGF-&#x3b2;RII directly correlated with RV1b mRNA. Finally, we found via flow cytometry that NK cells expressed less GARP surface-bound TGF-&#x3b2;, while cytokine-producing NK<sup>bright</sup> cells were induced. In summary, we show that rhinovirus infection inhibits TGF-&#x3b2; release in PBMCs, which results in the activation of both Treg and NK cells.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krammer</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1445-9555</Identifier><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Zuqin</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mitl&#xe4;nder</LastName><ForeName>Hannah</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grund</LastName><ForeName>Janina C</ForeName><Initials>JC</Initials><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Trump</LastName><ForeName>Sonja</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mittler</LastName><ForeName>Susanne</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zirlik</LastName><ForeName>Sabine</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medicine 1, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Finotto</LastName><ForeName>Susetta</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0001-7623-7977</Identifier><AffiliationInfo><Affiliation>Department of Molecular Pneumology, Friedrich-Alexander-Universit&#xe4;t (FAU) Erlangen-N&#xfc;rnberg, Universit&#xe4;tsklinikum Erlangen, 91054 Erlangen, Germany.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Cells</MedlineTA><NlmUniqueID>101600052</NlmUniqueID><ISSNLinking>2073-4409</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016212">Transforming Growth Factor beta</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053773">Transforming Growth Factor beta1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D008565">Membrane Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006023">Glycoproteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016212" MajorTopicYN="N">Transforming Growth Factor beta</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053773" MajorTopicYN="N">Transforming Growth Factor beta1</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012229" MajorTopicYN="N">Rhinovirus</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007963" MajorTopicYN="N">Leukocytes, Mononuclear</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008565" MajorTopicYN="N">Membrane Proteins</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D001249" MajorTopicYN="Y">Asthma</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="Y">Enterovirus Infections</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007694" MajorTopicYN="N">Killer Cells, Natural</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006023" MajorTopicYN="N">Glycoproteins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">NK cells</Keyword><Keyword MajorTopicYN="N">TGF-&#x3b2;</Keyword><Keyword MajorTopicYN="N">TGF-&#x3b2; RI</Keyword><Keyword MajorTopicYN="N">TGF-&#x3b2; RII</Keyword><Keyword MajorTopicYN="N">asthma</Keyword><Keyword MajorTopicYN="N">rhinovirus</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>11</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>12</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>1</Month><Day>8</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>1</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>1</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>28</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36611921</ArticleId><ArticleId IdType="pmc">PMC9818541</ArticleId><ArticleId IdType="doi">10.3390/cells12010129</ArticleId><ArticleId IdType="pii">cells12010129</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Global Asthma Network A.N.Z. The Global Asthma Report 2014&#x2014;Global Burden of Disease due to Asthma.  [(accessed on 17 September 2022)].  Available online:  http://globalasthmareport.org/2014/Global_Asthma_Report_2014.pdf.</Citation></Reference><Reference><Citation>Zheng S.-Y., Wang L.-L., Ren L., Luo J., Liao W., Liu E.-M. Epidemiological analysis and follow-up of human rhinovirus infection in children with asthma exacerbation. J. Med. Virol. 2018;90:219&#x2013;228. doi: 10.1002/jmv.24850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.24850</ArticleId><ArticleId IdType="pmc">PMC7167043</ArticleId><ArticleId IdType="pubmed">28500687</ArticleId></ArticleIdList></Reference><Reference><Citation>Nicholson K.G., Kent J., Ireland D.C. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307:982&#x2013;986. doi: 10.1136/bmj.307.6910.982.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.307.6910.982</ArticleId><ArticleId IdType="pmc">PMC1679193</ArticleId><ArticleId IdType="pubmed">8241910</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnston S.L., Pattemore P.K., Sanderson G., Smith S., Campbell M.J., Josephs L.K., Cunningham A., Robinson B.S., Myint S.H., Ward M.E., et al. The relationship between upper respiratory infections and hospital admissions for asthma: A time-trend analysis. Am. J. Respir. Crit. Care. Med. 1996;154:654&#x2013;660. doi: 10.1164/ajrccm.154.3.8810601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.154.3.8810601</ArticleId><ArticleId IdType="pubmed">8810601</ArticleId></ArticleIdList></Reference><Reference><Citation>Pauwels R.A., L&#xf6;fdahl C.G., Postma D.S., Tattersfield A.E., O&#x2019;Byrne P., Barnes P.J., Ullman A. Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group. N. Engl. J. Med. 1997;337:1405&#x2013;1411. doi: 10.1056/NEJM199711133372001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199711133372001</ArticleId><ArticleId IdType="pubmed">9358137</ArticleId></ArticleIdList></Reference><Reference><Citation>Pearlman D.S., LaForce C.F., Kaiser K. Fluticasone/Formoterol combination therapy compared with monotherapy in adolescent and adult patients with mild to moderate asthma. Clin. Ther. 2013;35:950&#x2013;966. doi: 10.1016/j.clinthera.2013.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinthera.2013.05.012</ArticleId><ArticleId IdType="pubmed">23870606</ArticleId></ArticleIdList></Reference><Reference><Citation>Schatz M., Meckley L.M., Kim M., Stockwell B.T., Castro M. Asthma exacerbation rates in adults are unchanged over a 5-year period despite high-intensity therapy. J. Allergy Clin. Immunol. Pract. 2014;2:570&#x2013;574.e571. doi: 10.1016/j.jaip.2014.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaip.2014.05.002</ArticleId><ArticleId IdType="pubmed">25213050</ArticleId></ArticleIdList></Reference><Reference><Citation>Palmenberg A.C., Spiro D., Kuzmickas R., Wang S., Djikeng A., Rathe J.A., Fraser-Liggett C.M., Liggett S.B. Sequencing and analyses of all known human rhinovirus genomes reveal structure and evolution. Science. 2009;324:55&#x2013;59. doi: 10.1126/science.1165557.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1165557</ArticleId><ArticleId IdType="pmc">PMC3923423</ArticleId><ArticleId IdType="pubmed">19213880</ArticleId></ArticleIdList></Reference><Reference><Citation>Schober D., Kronenberger P., Prchla E., Blaas D., Fuchs R. Major and minor receptor group human rhinoviruses penetrate from endosomes by different mechanisms. J. Virol. 1998;72:1354&#x2013;1364. doi: 10.1128/JVI.72.2.1354-1364.1998.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.72.2.1354-1364.1998</ArticleId><ArticleId IdType="pmc">PMC124614</ArticleId><ArticleId IdType="pubmed">9445036</ArticleId></ArticleIdList></Reference><Reference><Citation>Basnet S., Palmenberg A.C., Gern J.E. Rhinoviruses and Their Receptors. Chest. 2019;155:1018&#x2013;1025. doi: 10.1016/j.chest.2018.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2018.12.012</ArticleId><ArticleId IdType="pmc">PMC6533451</ArticleId><ArticleId IdType="pubmed">30659817</ArticleId></ArticleIdList></Reference><Reference><Citation>Cakebread J.A., Haitchi H.M., Xu Y., Holgate S.T., Roberts G., Davies D.E. Rhinovirus-16 induced release of IP-10 and IL-8 is augmented by Th2 cytokines in a pediatric bronchial epithelial cell model. PLoS ONE. 2014;9:e94010. doi: 10.1371/journal.pone.0094010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0094010</ArticleId><ArticleId IdType="pmc">PMC3976391</ArticleId><ArticleId IdType="pubmed">24705919</ArticleId></ArticleIdList></Reference><Reference><Citation>Papadopoulos N.G., Papi A., Meyer J., Stanciu L.A., Salvi S., Holgate S.T., Johnston S.L. Rhinovirus infection up-regulates eotaxin and eotaxin-2 expression in bronchial epithelial cells. Clin. Exp. Allergy. 2001;31:1060&#x2013;1066. doi: 10.1046/j.1365-2222.2001.01112.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2222.2001.01112.x</ArticleId><ArticleId IdType="pubmed">11467997</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan K.S., Ong H.H., Yan Y., Liu J., Li C., Ong Y.K., Thong K.T., Choi H.W., Wang D.-Y., Chow V.T. In vitro model of fully differentiated human nasal epithelial cells infected with rhinovirus reveals epithelium-initiated immune responses. J. Infect. Dis. 2018;217:906&#x2013;915. doi: 10.1093/infdis/jix640.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix640</ArticleId><ArticleId IdType="pubmed">29228279</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottoms S.E., Howell J.E., Reinhardt A.K., Evans I.C., McAnulty R.J. Tgf-Beta isoform specific regulation of airway inflammation and remodelling in a murine model of asthma. PLoS ONE. 2010;5:e9674. doi: 10.1371/journal.pone.0009674.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0009674</ArticleId><ArticleId IdType="pmc">PMC2837347</ArticleId><ArticleId IdType="pubmed">20300191</ArticleId></ArticleIdList></Reference><Reference><Citation>Konkel J.E., Zhang D., Zanvit P., Chia C., Zangarle-Murray T., Jin W., Wang S., Chen W. Transforming Growth Factor-&#x3b2; Signaling in Regulatory T Cells Controls T Helper-17 Cells and Tissue-Specific Immune Responses. Immunity. 2017;46:660&#x2013;674. doi: 10.1016/j.immuni.2017.03.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2017.03.015</ArticleId><ArticleId IdType="pubmed">28423340</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Wan Q., Kozhaya L., Fujii H., Unutmaz D. Identification of a regulatory T cell specific cell surface molecule that mediates suppressive signals and induces Foxp3 expression. PLoS ONE. 2008;3:e2705. doi: 10.1371/journal.pone.0002705.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0002705</ArticleId><ArticleId IdType="pmc">PMC2442191</ArticleId><ArticleId IdType="pubmed">18628982</ArticleId></ArticleIdList></Reference><Reference><Citation>Tran D.Q., Andersson J., Wang R., Ramsey H., Unutmaz D., Shevach E.M. GARP (LRRC32) is essential for the surface expression of latent TGF-beta on platelets and activated FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2009;106:13445&#x2013;13450. doi: 10.1073/pnas.0901944106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901944106</ArticleId><ArticleId IdType="pmc">PMC2726354</ArticleId><ArticleId IdType="pubmed">19651619</ArticleId></ArticleIdList></Reference><Reference><Citation>Munger J.S., Huang X., Kawakatsu H., Griffiths M.J., Dalton S.L., Wu J., Pittet J.F., Kaminski N., Garat C., Matthay M.A., et al. The integrin alpha v beta 6 binds and activates latent TGF beta 1: A mechanism for regulating pulmonary inflammation and fibrosis. Cell. 1999;96:319&#x2013;328. doi: 10.1016/S0092-8674(00)80545-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0092-8674(00)80545-0</ArticleId><ArticleId IdType="pubmed">10025398</ArticleId></ArticleIdList></Reference><Reference><Citation>Bielor C., Sopel N., Maier A., Blau A., Sharma H., Vuorinen T., Kross B., Mittler S., Graser A., Mousset S., et al. Role of TGF-beta in anti-rhinovirus immune responses in asthmatic patients. J. Allergy. Clin. Immunol. 2017;140:283&#x2013;286.e210. doi: 10.1016/j.jaci.2016.10.049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2016.10.049</ArticleId><ArticleId IdType="pmc">PMC5754331</ArticleId><ArticleId IdType="pubmed">28139316</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergauer A., Sopel N., Kro&#xdf; B., Vuorinen T., Xepapadaki P., Weiss S.T., Blau A., Sharma H., Kraus C., Springel R., et al. IFN-&#x3b1;/IFN-&#x3bb; responses to respiratory viruses in paediatric asthma. Eur. Respir. J. 2017;49:1600969. doi: 10.1183/13993003.00969-2016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.00969-2016</ArticleId><ArticleId IdType="pubmed">27836955</ArticleId></ArticleIdList></Reference><Reference><Citation>Graser A., Ekici A.B., Sopel N., Melichar V.O., Zimmermann T., Papadopoulos N.G., Taka S., Ferrazzi F., Vuorinen T., Finotto S. Rhinovirus inhibits IL-17A and the downstream immune responses in allergic asthma. Mucosal. Immunol. 2016;9:1183&#x2013;1192. doi: 10.1038/mi.2015.130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/mi.2015.130</ArticleId><ArticleId IdType="pmc">PMC7099698</ArticleId><ArticleId IdType="pubmed">26732679</ArticleId></ArticleIdList></Reference><Reference><Citation>Spyridaki I., Taka S., Skevaki C., Trochoutsou A., Papadopoulos N.G. In Vitro Effects of 5-Lipoxygenase Pathway Inhibition on Rhinovirus-Associated Bronchial Epithelial Inflammation. Pulm. Ther. 2021;7:237&#x2013;249. doi: 10.1007/s41030-021-00152-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s41030-021-00152-x</ArticleId><ArticleId IdType="pmc">PMC8137792</ArticleId><ArticleId IdType="pubmed">33847974</ArticleId></ArticleIdList></Reference><Reference><Citation>Fehniger T.A., Shah M.H., Turner M.J., VanDeusen J.B., Whitman S.P., Cooper M.A., Suzuki K., Wechser M., Goodsaid F., Caligiuri M.A. Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: Implications for the innate immune response. J. Immunol. 1999;162:4511&#x2013;4520.</Citation><ArticleIdList><ArticleId IdType="pubmed">10201989</ArticleId></ArticleIdList></Reference><Reference><Citation>La J., Reed E., Chan L., Smolyaninova L.V., Akomova O.A., Mutlu G.M., Orlov S.N., Dulin N.O. Downregulation of TGF-&#x3b2; Receptor-2 Expression and Signaling through Inhibition of Na/K-ATPase. PLoS ONE. 2016;11:e0168363. doi: 10.1371/journal.pone.0168363.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0168363</ArticleId><ArticleId IdType="pmc">PMC5179089</ArticleId><ArticleId IdType="pubmed">28006004</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y.W., Park J., Lee H.J., Lee S.Y., Kim S.J. TGF-&#x3b2; sensitivity is determined by N-linked glycosylation of the type II TGF-&#x3b2; receptor. Biochem. J. 2012;445:403&#x2013;411. doi: 10.1042/BJ20111923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1042/BJ20111923</ArticleId><ArticleId IdType="pmc">PMC3462611</ArticleId><ArticleId IdType="pubmed">22571197</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R., Kozhaya L., Mercer F., Khaitan A., Fujii H., Unutmaz D. Expression of GARP selectively identifies activated human FOXP3+ regulatory T cells. Proc. Natl. Acad. Sci. USA. 2009;106:13439&#x2013;13444. doi: 10.1073/pnas.0901965106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0901965106</ArticleId><ArticleId IdType="pmc">PMC2726405</ArticleId><ArticleId IdType="pubmed">19666573</ArticleId></ArticleIdList></Reference><Reference><Citation>Stockis J., Colau D., Coulie P.G., Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur. J. Immunol. 2009;39:3315&#x2013;3322. doi: 10.1002/eji.200939684.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.200939684</ArticleId><ArticleId IdType="pubmed">19750484</ArticleId></ArticleIdList></Reference><Reference><Citation>Metelli A., Salem M., Wallace C.H., Wu B.X., Li A., Li X., Li Z. Immunoregulatory functions and the therapeutic implications of GARP-TGF-&#x3b2; in inflammation and cancer. J. Hematol. Oncol. 2018;11:24. doi: 10.1186/s13045-018-0570-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13045-018-0570-z</ArticleId><ArticleId IdType="pmc">PMC5819195</ArticleId><ArticleId IdType="pubmed">29458436</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunwell J.R., Yeligar S.M., Stephenson S., Ping X.D., Gauthier T.W., Fitzpatrick A.M., Brown L.A.S. TGF-&#x3b2;1 Suppresses the Type I IFN Response and Induces Mitochondrial Dysfunction in Alveolar Macrophages. J. Immunol. 2018;200:2115&#x2013;2128. doi: 10.4049/jimmunol.1701325.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1701325</ArticleId><ArticleId IdType="pmc">PMC5928790</ArticleId><ArticleId IdType="pubmed">29427413</ArticleId></ArticleIdList></Reference><Reference><Citation>Ranges G.E., Figari I.S., Espevik T., Palladino M., Jr. Inhibition of cytotoxic T cell development by transforming growth factor beta and reversal by recombinant tumor necrosis factor alpha. J. Exp. Med. 1987;166:991&#x2013;998. doi: 10.1084/jem.166.4.991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.166.4.991</ArticleId><ArticleId IdType="pmc">PMC2188710</ArticleId><ArticleId IdType="pubmed">3498791</ArticleId></ArticleIdList></Reference><Reference><Citation>Laouar Y., Sutterwala F.S., Gorelik L., Flavell R.A. Transforming growth factor-&#x3b2; controls T helper type 1 cell development through regulation of natural killer cell interferon-&#x3b3;. Nat. Immunol. 2005;6:600&#x2013;607. doi: 10.1038/ni1197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1197</ArticleId><ArticleId IdType="pubmed">15852008</ArticleId></ArticleIdList></Reference><Reference><Citation>Horwitz D.A., Gray J.D., Ohtsuka K. Role of NK cells and TGF-&#x3b2; in the regulation of T-cell-dependent antibody production in health and autoimmune disease. Microbes Infect. 1999;1:1305&#x2013;1311. doi: 10.1016/S1286-4579(99)00253-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1286-4579(99)00253-1</ArticleId><ArticleId IdType="pubmed">10611759</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu J., Wei M., Becknell B., Trotta R., Liu S., Boyd Z., Jaung M.S., Blaser B.W., Sun J., Benson D.M., Jr., et al. Pro- and antiinflammatory cytokine signaling: Reciprocal antagonism regulates interferon-gamma production by human natural killer cells. Immunity. 2006;24:575&#x2013;590. doi: 10.1016/j.immuni.2006.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2006.03.016</ArticleId><ArticleId IdType="pubmed">16713975</ArticleId></ArticleIdList></Reference><Reference><Citation>Witkowski M., Tizian C., Ferreira-Gomes M., Niemeyer D., Jones T.C., Heinrich F., Frischbutter S., Angermair S., Hohnstein T., Mattiola I., et al. Untimely TGF&#x3b2; responses in COVID-19 limit antiviral functions of NK cells. Nature. 2021;600:295&#x2013;301. doi: 10.1038/s41586-021-04142-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-04142-6</ArticleId><ArticleId IdType="pubmed">34695836</ArticleId></ArticleIdList></Reference><Reference><Citation>Viel S., Mar&#xe7;ais A., Guimaraes F.S., Loftus R., Rabilloud J., Grau M., Degouve S., Djebali S., Sanlaville A., Charrier E., et al. TGF-&#x3b2; inhibits the activation and functions of NK cells by repressing the mTOR pathway. Sci. Signal. 2016;9:ra19. doi: 10.1126/scisignal.aad1884.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scisignal.aad1884</ArticleId><ArticleId IdType="pubmed">26884601</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinette M.L., Fuchs A., Cortez V.S., Lee J.S., Wang Y., Durum S.K., Gilfillan S., Colonna M. Transcriptional programs define molecular characteristics of innate lymphoid cell classes and subsets. Nat. Immunol. 2015;16:306&#x2013;317. doi: 10.1038/ni.3094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3094</ArticleId><ArticleId IdType="pmc">PMC4372143</ArticleId><ArticleId IdType="pubmed">25621825</ArticleId></ArticleIdList></Reference><Reference><Citation>Gao Y., Souza-Fonseca-Guimaraes F., Bald T., Ng S.S., Young A., Ngiow S.F., Rautela J., Straube J., Waddell N., Blake S.J., et al. Tumor immunoevasion by the conversion of effector NK cells into type 1 innate lymphoid cells. Nat. Immunol. 2017;18:1004&#x2013;1015. doi: 10.1038/ni.3800.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3800</ArticleId><ArticleId IdType="pubmed">28759001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellone G., Aste-Amezaga M., Trinchieri G., Rodeck U. Regulation of NK cell functions by TGF-beta 1. J. Immunol. 1995;155:1066&#x2013;1073.</Citation><ArticleIdList><ArticleId IdType="pubmed">7636180</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B.J., Lindsay M., Dagher H., Freezer N.J., Li D., Ghildyal R., Bardin P.G. Transforming Growth Factor-&#x3b2; Enhances Rhinovirus Infection by Diminishing Early Innate Responses. Am. J. Respir. Cell. Mol. Biol. 2009;41:339&#x2013;347. doi: 10.1165/rcmb.2008-0316OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1165/rcmb.2008-0316OC</ArticleId><ArticleId IdType="pubmed">19168696</ArticleId></ArticleIdList></Reference><Reference><Citation>Bedke N., Sammut D., Green B., Kehagia V., Dennison P., Jenkins G., Tatler A., Howarth P.H., Holgate S.T., Davies D.E. Transforming growth factor-beta promotes rhinovirus replication in bronchial epithelial cells by suppressing the innate immune response. PLoS ONE. 2012;7:e44580. doi: 10.1371/journal.pone.0044580.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0044580</ArticleId><ArticleId IdType="pmc">PMC3435262</ArticleId><ArticleId IdType="pubmed">22970254</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>